David N. Baxter
Stepping Hill Hospital
Stockport, ENG, United Kingdom
Stockport, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Lessons in resourcefulness: the SBNS Caribbean Training Fellowship.
Journal: British journal of neurosurgery
Published: June 18, 2026
Spinal cord stimulation to manage autonomic dysfunction after spinal cord injury: a systematic review.
Journal: Frontiers in human neuroscience
Published: December 08, 2025
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.
Journal: The Journal of infection
Published: March 11, 2025
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Journal: Epidemiology and infection
Published: January 22, 2024
Genomic landscape of diffuse glioma revealed by whole genome sequencing.
Journal: Nature communications
Published: October 27, 2023
Ward-based in situ simulation: lessons learnt from a UK District General Hospital.
Journal: BMJ open quality
Published: August 20, 2023
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Journal: The Journal of infection
Published: April 13, 2023
The impact of Longitudinal Integrated Foundation Training: preliminary experiences in the United Kingdom.
Journal: BMC medical education
Published: March 31, 2023
The imaging of cervical spondylotic myeloradiculopathy.
Journal: Skeletal radiology
Published: February 04, 2023
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Journal: The Journal of infection
Published: January 11, 2023
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 07, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Journal: The Lancet. Infectious diseases
Published: April 12, 2022
Last Updated: 09/26/2026